Pattern Of Use Of Belatacept In US Transplant Recipients
Phase of Trial: Phase IV
Latest Information Update: 19 Jul 2018
At a glance
- Drugs Belatacept (Primary) ; Calcineurin inhibitors
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 12 Jul 2018 Status changed from active, no longer recruiting to completed.
- 07 Aug 2017 Planned End Date changed from 30 Jun 2017 to 30 Jun 2018.
- 07 Aug 2017 Planned primary completion date changed from 30 Jun 2017 to 30 Jun 2018.